Bryan Hanley is a graduate of the University of St Andrews (BSc Chemistry) and the University of Edinburgh (PhD Biological Chemistry). He currently works for the Knowledge Transfer Network. Prior to this he held the post of Director, Scientific Discovery with Mars Inc. based in Chicago. He was responsible for the science of both the internal and the external programmes in oral health and in psychological aspects of chewing and mastication. He was a member
Talk: Health and Wellbeing with KTN Ltd
The importance of long term health and the various components that contribute to this has been recognised for a number of years. On the one hand, preventative medicine has become a major goal, particularly in societies where chronic diseases such as cardiovascular disease, diabetes and age-related cognitive impairment have become important and costly issues. This has taken a number of forms including the increased use of drugs to control blood pressure, cholesterol and other avoidable deleterious conditions. Increasingly, however, a non-pharmaceutical, lifestyle related intervention strategy has been adopted. In this case the use of diet to control physiological endpoints and to improve overall health has been advocated.
While such approaches are tempting and indeed have led to substantial testing of minor dietary components such as phenols, plant stanols and sterols, isothiocyanates and others, it remains stubbornly the case that the best dietary advice for many people suffering from chronic disease would be to eat less, reduce their weight and take more exercise.
It is against this background that the KTN works to ensure the best new technologies across a range of disciplines from food & agriculture, health, medical and medicinal interventions, remote sensing and biomarker technology and epidemiology and consumer awareness are supported by ensuring the free flow of information between research providers and user communities both within and between disciplines. The adoption of the best technologies and their application will ultimately lead to improvements in health, reduction in healthcare costs and increased profits for companies in the sector. This latter point is particularly important since it is by rewarding innovative and innovating companies that new ideas will be generated and the best and most nimble minds will congregate.
of the Mars Scientific Leadership Team and the Innovation Leadership Team. He has previously worked both in the commercial and public sectors and his interests include natural products, biomarkers, the relationship between health and homeostasis and the commercial application of science. He has held positions in both the public and private sectors.
He is a Fellow of the Royal Society of Chemistry and of the Institute of Food Science and Nutrition. He is President of the Industry and Technology Division of the Royal Society of Chemistry. He is also a member of the Food Group Committee of the Society of Chemical Industry and a member of the Nutrition Society. He is Visiting Professor in the School of Biomedical Sciences, the University of Ulster. He has published over 70 peer reviewed articles, patents and reviews and had spoken at numerous national and international meetings.